Privitera, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 165
EU - Europa 115
AS - Asia 44
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 327
Nazione #
US - Stati Uniti d'America 165
SE - Svezia 45
IT - Italia 22
SG - Singapore 17
IE - Irlanda 16
CN - Cina 11
DE - Germania 11
ID - Indonesia 9
FR - Francia 8
IR - Iran 4
BE - Belgio 3
CZ - Repubblica Ceca 3
CI - Costa d'Avorio 2
IN - India 2
RU - Federazione Russa 2
UA - Ucraina 2
AZ - Azerbaigian 1
CH - Svizzera 1
EU - Europa 1
FI - Finlandia 1
NL - Olanda 1
Totale 327
Città #
Chandler 55
Ashburn 23
Dublin 16
Singapore 15
New York 14
Jakarta 9
Marseille 7
Bremen 6
Princeton 6
Cagliari 5
Boston 4
Los Angeles 4
Milan 4
Brussels 3
San Mateo 3
Abidjan 2
Brdo 2
Fairfield 2
Kish 2
Pavia 2
Pune 2
Rome 2
San Diego 2
Washington 2
Ann Arbor 1
Atlanta 1
Baku 1
Beijing 1
Bellano 1
Boardman 1
Boydton 1
Brno 1
Chicago 1
Corigliano d'Otranto 1
Kashan 1
Lappeenranta 1
Moscow 1
Rotterdam 1
Sacramento 1
Seattle 1
Springfield 1
Taranto 1
Wilmington 1
Zurich 1
Totale 212
Nome #
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence 59
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 54
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 46
Novel Insights Into the Interactions Between the Gut Microbiome, Inflammasomes, and Gasdermins During Colorectal Cancer 41
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 40
Predictors and early markers of response to biological therapies in inflammatory bowel diseases 37
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 32
The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19 19
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 11
Totale 339
Categoria #
all - tutte 2.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 1 0 0 1 5 0
2021/202252 1 0 1 4 0 3 0 5 0 10 13 15
2022/2023152 22 21 14 25 10 11 10 9 27 2 1 0
2023/2024108 4 21 6 9 5 23 7 1 5 4 12 11
2024/202520 1 3 16 0 0 0 0 0 0 0 0 0
Totale 339